Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2024)
Eton Pharmaceuticals' (ETON) quarterly Non Operating Income came in at -$1.1 million in Q4 2024, down 7025.0% year-on-year from $16462.1 in Q1 2024, and down 14150.0% quarter-over-quarter from -$8000.0 in Q3 2024.
Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2024) Analysis & Trends
Eton Pharmaceuticals has disclosed Non Operating Income across 6 years of filings, most recently posting -$1.1 million for Q4 2024.
- Non Operating Income for Q4 2024 came in at -$1.1 million, down 7025.0% year-over-year; the trailing twelve-month figure through Dec 2024 was -$1.2 million (down 340.76% YoY), and the FY2025 annual result was -$3.7 million, down 206.69% from the prior year.
- Non Operating Income came in at -$1.1 million for Q4 2024 at Eton Pharmaceuticals, down from -$8000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $676000.0 in Q2 2023 to a low of -$1.1 million in Q4 2024.
- The 5-year median for Non Operating Income is -$171000.0 (2020), against an average of -$149900.0.
- Across the five-year window, Non Operating Income surged 410.09% in 2023 and tumbled 7025.0% in 2024, its largest moves.
- Eton Pharmaceuticals' Non Operating Income stood at -$267000.0 in 2020, then declined by 3.0% to -$275000.0 in 2021, then surged by 45.45% to -$150000.0 in 2022, then soared by 89.33% to -$16000.0 in 2023, then sank by 7025.0% to -$1.1 million in 2024.
- The last three Non Operating Income figures came in at -$1.1 million (Q4 2024), -$8000.0 (Q3 2024), and -$52000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Eton Pharmaceuticals | 820.42 Mn | 794.48 Mn | 13.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.14 Mn |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -52,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | -16,000.00 |
| Sep 30, 2023 | -31,000.00 |
| Jun 30, 2023 | 676,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Dec 31, 2022 | -150,000.00 |
| Sep 30, 2022 | -150,000.00 |
| Jun 30, 2022 | -218,000.00 |
| Mar 31, 2022 | -243,000.00 |
| Dec 31, 2021 | -275,000.00 |
| Sep 30, 2021 | -247,000.00 |
| Jun 30, 2021 | -237,000.00 |
| Mar 31, 2021 | -247,000.00 |
| Dec 31, 2020 | -267,000.00 |
| Sep 30, 2020 | -232,000.00 |
| Jun 30, 2020 | -192,000.00 |
| Mar 31, 2020 | 168,000.00 |